-
SHIRE PHARMACEUTICAL DEVELOPMENT INC. et al v. AMNEAL PHARMACEUTICALS LLC et al DC
- 1:15-cv-02865
- D.N.J.
- Judge: Robert B. Kugler
+1
- Filed: 04/22/2015
- Closed: 05/21/2018
- Latest Docket Entry: 03/14/2019
- PACER
4
Plaintiffs
3
Defendants
9
Accused
Products
1
Patent-in-Suit
1,126
Days in
Litigation
-
SHIRE PHARMACEUTICAL DEVELOPMENT INC. et al v. AMNEAL PHARMACEUTICALS LLC et al DC
- 1:15-cv-02865
- D.N.J.
- Judge: Robert B. Kugler
+1
- Filed: 04/22/2015
- Closed: 05/21/2018
- Latest Docket Entry: 03/14/2019
- PACER
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Amneal Life Sciences Private Limited
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Metaxalone Tablets 800 mgTramadol/APAP Tablets 37.5/325 mgWarfarin Sodium Tablets 10 mgWarfarin Sodium Tablets 1 mgWarfarin Sodium Tablets 2.5 mgWarfarin Sodium Tablets 2 mgWarfarin Sodium Tablets 3 mgWarfarin Sodium Tablets 4 mgWarfarin Sodium Tablets 5 mgWarfarin Sodium Tablets 6 mgWarfarin Sodium Tablets 7.5 mg | US 6,773,720 B1 | All Asserted Claims |
No infringement
Entry 369
|
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Metaxalone Tablets 800 mgTramadol/APAP Tablets 37.5/325 mgWarfarin Sodium Tablets 10 mgWarfarin Sodium Tablets 1 mgWarfarin Sodium Tablets 2.5 mgWarfarin Sodium Tablets 2 mgWarfarin Sodium Tablets 3 mgWarfarin Sodium Tablets 4 mgWarfarin Sodium Tablets 5 mgWarfarin Sodium Tablets 6 mgWarfarin Sodium Tablets 7.5 mg | US 6,773,720 B1 | All Asserted Claims |
No infringement
Entry 369
|
Amneal Pharmaceuticals, LLC
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Metaxalone Tablets 800 mgTramadol/APAP Tablets 37.5/325 mgWarfarin Sodium Tablets 10 mgWarfarin Sodium Tablets 1 mgWarfarin Sodium Tablets 2.5 mgWarfarin Sodium Tablets 2 mgWarfarin Sodium Tablets 3 mgWarfarin Sodium Tablets 4 mgWarfarin Sodium Tablets 5 mgWarfarin Sodium Tablets 6 mgWarfarin Sodium Tablets 7.5 mg | US 6,773,720 B1 | All Asserted Claims |
No infringement
Entry 369
|